Infoholic Research LLP

Factors, such as growing incidence of cancer cases and lifestyle diseases globally, the cost-effectiveness of biosimilars over biologics, and strategic collaboration to develop new biosimilar drugs will increase the market growth during the forecast period.

Factors such as technological advancements in 3D mammography, increasing incidence of breast cancer, government initiatives for breast cancer awareness and treatments are expected to drive the market growth during forecast period